Xiaofeng Lu
Impact in
- Microbiology top 2%
- Antimicrobial Peptides and Activities
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Papers in
-
- RNA Interference and Gene Delivery 10
- Cell death mechanisms and regulation 8
- Glycosylation and Glycoproteins Research 7
- Immunology 28
- Co-authors
- Hao Yang (42 shared papers)Jingqiu Cheng (29 shared papers)Lin Wan (25 shared papers)Roman Dziarski (2 shared papers)Dipika Gupta (2 shared papers)Xinna Li (2 shared papers)Huawei Cai (18 shared papers)Shengfu Li (25 shared papers)
- Journals
- Applied Microbiology and Biotechnology (8 papers)Frontiers in Oncology (6 papers)Molecular Pharmaceutics (5 papers)Journal of Controlled Release (4 papers)Protein Expression and Purification (3 papers)
- Partner nations
- ChinaUnited StatesIndia
In The Last Decade
Xiaofeng Lu
162 papers receiving 3.3k citations
Peers
Comparison fields: 5 of 134
- Microbiology 223
- Cancer Research 388
- Immunology 505
- Molecular Biology 1.3k
- Oncology 362
Countries citing papers authored by Xiaofeng Lu
This map shows the geographic impact of Xiaofeng Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaofeng Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaofeng Lu more than expected).
Fields of papers citing papers by Xiaofeng Lu
This network shows the impact of papers produced by Xiaofeng Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaofeng Lu. The network helps show where Xiaofeng Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaofeng Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 169 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 187 | |
| 2 | 2007 | 155 | |
| 3 | 2009 | 122 | |
| 4 | 2010 | 120 | |
| 5 | 2020 | 112 | |
| 6 | 2007 | 103 | |
| 7 | 2022 | 89 | |
| 8 | 2016 | 74 | |
| 9 | 2006 | 70 | |
| 10 | 2021 | 65 | |
| 11 | 2010 | 63 | |
| 12 | 2018 | 57 | |
| 13 | 2018 | 56 | |
| 14 | 2009 | 56 | |
| 15 | 2018 | 48 | |
| 16 | 2016 | 46 | |
| 17 | 2007 | 44 | |
| 18 | 2020 | 44 | |
| 19 | 2009 | 42 | |
| 20 | 2017 | 41 |
About Xiaofeng Lu
Xiaofeng Lu is a scholar working on Molecular Biology, Immunology, Surgery, Radiology, Nuclear Medicine and Imaging and Oncology, having authored 169 papers that have together received 3.4k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (18 papers), Gastric Cancer Management and Outcomes (11 papers), RNA Interference and Gene Delivery (10 papers), Cell death mechanisms and regulation (8 papers), Nanoparticle-Based Drug Delivery (8 papers), Glycosylation and Glycoproteins Research (7 papers), Bone Tissue Engineering Materials (7 papers) and Antimicrobial Peptides and Activities (7 papers). The work is most often cited by research in Microbiology (223 citations), Cancer Research (388 citations), Immunology (505 citations), Molecular Biology (1.3k citations) and Oncology (362 citations). Xiaofeng Lu has collaborated with scholars based in China, United States and India. Frequent co-authors include Hao Yang, Jingqiu Cheng, Lin Wan, Roman Dziarski, Dipika Gupta, Xinna Li, Huawei Cai, Shengfu Li, Qi Ma and Ze Tao. Their work appears in journals such as Applied Microbiology and Biotechnology, Frontiers in Oncology, Molecular Pharmaceutics, Journal of Controlled Release and Protein Expression and Purification.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.